BioSig Technologies, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BioSig Technologies, Inc. (BSGM) on April 30, 2021, reporting events that occurred on April 28, 2021. The company is incorporated in Delaware and trades on the NASDAQ Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
The primary material change reported is the departure of two directors from the Board of Directors:
- Andrew L. Filler: Informed the company he will not stand for re-election at the 2021 Annual Meeting of Stockholders (scheduled for June 28, 2021) and will retire upon the expiration of his term.
- Martha Pease: Informed the company she will not stand for re-election at the 2021 Annual Meeting and will retire upon the expiration of her term.
Both departures were stated to be unrelated to any disagreement with the Company regarding operations, policies, or practices. Following these retirements, the Board determined to reduce its size to seven members.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. Management commentary is limited to the rationale for reducing the Board size, which is deemed appropriate for the company's current market capitalization.
Investor Verification Checklist
- Verify the exact date of the 2021 Annual Meeting of Stockholders (stated as June 28, 2021).
- Confirm the new composition of the Board of Directors following the reduction to seven members.
- Review the company's most recent 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.